权益类FOF上周最高收益率超6%,公募近期重点调研医药生物行业
Mei Ri Jing Ji Xin Wen·2026-01-12 11:04

Group 1 - The Shanghai Composite Index has shown a continuous upward trend, achieving a 16-day winning streak and surpassing 4100 points, with significant gains in various sectors including defense, media, and non-ferrous metals [1][3] - Equity FOF funds have performed well, with stock-type FOFs showing the highest weekly returns, some exceeding 6%, indicating strong investor demand for asset allocation products [1][3] - The issuance of public funds has increased, with 91 new funds launched in early 2026, reflecting optimistic expectations for equity assets among institutions [2][3] Group 2 - The brain-computer interface sector has gained attention following Elon Musk's announcement regarding Neuralink's plans for large-scale production, with market forecasts predicting the medical application market could reach $40 billion by 2030 [2][3] - The pharmaceutical and biotechnology sectors have been a focus for public fund research, with 89 investigations in the past week, indicating strong interest in this area [3][4] - The Hong Kong pharmaceutical sector has seen significant growth driven by ongoing medical demand and supportive policies, attracting substantial investment and boosting related indices [4]